Longitudinal Predictors of Human Papillomavirus Vaccination Among a National Sample of Adolescent Males
Paul L. Reiter,Annie Laurie McRee,Jessica K. Pepper,Melissa B. Gilkey,Kayoll V. Galbraith,Noel T. Brewer +5 more
Reads0
Chats0
TLDR
Vaccination against HPV remained low in this study and willingness to vaccinate may be decreasing, and physician recommendation and education about HPV vaccine for males may be key strategies for improving vaccination.Abstract:
Objectives. We conducted a longitudinal study to examine human papillomavirus (HPV) vaccine uptake among male adolescents and to identify vaccination predictors.Methods. In fall 2010 and 2011, a national sample of parents with sons aged 11 to 17 years (n = 327) and their sons (n = 228) completed online surveys. We used logistic regression to identify predictors of HPV vaccination that occurred between baseline and follow-up.Results. Only 2% of sons had received any doses of HPV vaccine at baseline, with an increase to 8% by follow-up. About 55% of parents who had ever received a doctor’s recommendation to get their sons HPV vaccine did vaccinate between baseline and follow-up, compared with only 1% of parents without a recommendation. Fathers (odds ratio = 0.29; 95% confidence interval = 0.09, 0.80) and non-Hispanic White parents (odds ratio = 0.29; 95% confidence interval = 0.11, 0.76) were less likely to have vaccinated sons. Willingness to get sons HPV vaccine decreased from baseline to follow-up among...read more
Citations
More filters
Journal ArticleDOI
Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?
TL;DR: Many adults are willing to get a COVID-19 vaccine, though acceptability should be monitored as vaccine development continues.
Journal ArticleDOI
Increasing Vaccination: Putting Psychological Science Into Action:
TL;DR: It is found that few randomized trials have successfully changed what people think and feel about vaccines, and those that succeeded were minimally effective in increasing uptake.
Journal ArticleDOI
Provider communication and HPV vaccination: The impact of recommendation quality.
Melissa B. Gilkey,William A. Calo,Jennifer L. Moss,Parth D. Shah,Macary Weck Marciniak,Noel T. Brewer +5 more
TL;DR: High-quality recommendations were strongly associated with HPV vaccination behavior, but only about one-third of parents received them; interventions are needed to improve not only whether, but how providers recommend HPV vaccination for adolescents.
Journal ArticleDOI
Provider communication about HPV vaccination: A systematic review.
TL;DR: Interventions are needed to help providers deliver effective recommendations in the complex communication environment surrounding HPV vaccination.
Journal ArticleDOI
Parents' uptake of human papillomavirus vaccines for their children: a systematic review and meta-analysis of observational studies.
Peter A. Newman,Carmen H. Logie,Ashley Lacombe-Duncan,Philip Baiden,Suchon Tepjan,Clara Rubincam,Nick Doukas,Farid Asey +7 more
TL;DR: Suboptimal levels of HPV vaccine uptake, twofold lower among boys, that may be improved by increasing physician recommendations, addressing parental safety concerns and promoting parents’ positive beliefs about vaccines, in addition to expanding insurance coverage and reducing out-of-pocket costs are indicated.
References
More filters
Journal Article
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Lauri E. Markowitz,Eileen F. Dunne,Mona Saraiya,Herschel W. Lawson,Harrell W. Chesson,Elizabeth R. Unger +5 more
TL;DR: The first statement by the Advisory Committee on Immunization Practices (ACIP) on the use of a quadrivalent human papillomavirus (HPV) vaccine was made by the U.S. Food and Drug Administration on June 8, 2006 as mentioned in this paper.
Journal ArticleDOI
Predictors of HPV vaccine acceptability: A theory-informed, systematic review
Noel T. Brewer,Karah I. Fazekas +1 more
TL;DR: HPV vaccine programs in the United States should emphasize high vaccine effectiveness, the high likelihood of HPV infection, and physicians' recommendations, and address barriers to vaccination.
Journal ArticleDOI
Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease.
TL;DR: A quadrivalent HPV-6/11/16/18 vaccine (Merck/SPMSD) has shown essentially 100% protection against ano-genital warts (GWs) in women in early studies as mentioned in this paper.